M&A Deal Summary

Alvogen Acquires Dream Pharma

On August 6, 2014, Alvogen acquired life science company Dream Pharma for 187M USD

Acquisition Highlights
  • This is Alvogen’s 4th transaction in the Life Science sector.
  • This is Alvogen’s largest (disclosed) transaction.
  • This is Alvogen’s 2nd transaction in South Korea.

M&A Deal Summary
Date 2014-08-06
Target Dream Pharma
Sector Life Science
Buyer(s) Alvogen
Deal Type Add-on Acquisition
Deal Value 187M USD

Target

Dream Pharma

Seoul, South Korea
Dream Pharma Corp. is a generic pharmaceutical company.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alvogen

Morristown, New Jersey, United States
Category Company
Founded 2009
Sector Life Science
Employees2,000
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology, and gastroenterology. Alvogen has commercial operations in over 30 countries across North America, Central and Eastern Europe, and the Asia Pacific. Alvogen was founded in 2009 and is based in Morristown, New Jersey.

DEAL STATS #
Overall 4 of 8
Sector (Life Science) 4 of 8
Type (Add-on Acquisition) 2 of 3
Country (South Korea) 2 of 2
Year (2014) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-31 LaborMed Pharma

Ljubljana, Romania

LaborMed Pharma is a manufacturer and distributor generic pharmaceuticals primarily for cardiovascular and central nervous system aliments. The Company has also launched a portfolio of drugs for diabetes. LaborMed Pharma is based in Ljubljana, Romania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-06 Bayer Pharma AG - Hormonal Branded Products

Russia

Bayer Pharma AG - Hormonal Branded Products - Klimonorm (Hormone replacement therapy), Progynova (Hormone replacement therapy), Triquilar ( Female contraception) and Microgynon (Female contraception) and Climene (Hormone replacement therapy).

Buy -
Mergr

Product

Company

Legal